These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37552802)
21. Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome. Spencer KA; Mulholland M; Snell J; Howe M; James K; Hanaford AR; Morgan PG; Sedensky M; Johnson SC Br J Anaesth; 2023 Nov; 131(5):832-846. PubMed ID: 37770252 [TBL] [Abstract][Full Text] [Related]
22. Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome. Bitto A; Grillo AS; Ito TK; Stanaway IB; Nguyen BMG; Ying K; Tung H; Smith K; Tran N; Velikanje G; Urfer SR; Snyder JM; Barton J; Sharma A; Kayser EB; Wang L; Smith DL; Thompson JW; DuBois L; DePaolo W; Kaeberlein M Nat Metab; 2023 Jun; 5(6):955-967. PubMed ID: 37365290 [TBL] [Abstract][Full Text] [Related]
23. Ndufs4 KO mice: A model to study comorbid mood disorders associated with mitochondrial dysfunction. van Rensburg DJ; Lindeque Z; Harvey BH; Steyn SF Pharmacol Biochem Behav; 2024 Jan; 234():173689. PubMed ID: 38070656 [TBL] [Abstract][Full Text] [Related]
24. NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement. Leshinsky-Silver E; Lebre AS; Minai L; Saada A; Steffann J; Cohen S; Rötig A; Munnich A; Lev D; Lerman-Sagie T Mol Genet Metab; 2009 Jul; 97(3):185-9. PubMed ID: 19364667 [TBL] [Abstract][Full Text] [Related]
25. Gene replacement therapy provides benefit in an adult mouse model of Leigh syndrome. Reynaud-Dulaurier R; Benegiamo G; Marrocco E; Al-Tannir R; Surace EM; Auwerx J; Decressac M Brain; 2020 Jun; 143(6):1686-1696. PubMed ID: 32413099 [TBL] [Abstract][Full Text] [Related]
26. Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome. Ferrari M; Jain IH; Goldberger O; Rezoagli E; Thoonen R; Cheng KH; Sosnovik DE; Scherrer-Crosbie M; Mootha VK; Zapol WM Proc Natl Acad Sci U S A; 2017 May; 114(21):E4241-E4250. PubMed ID: 28483998 [TBL] [Abstract][Full Text] [Related]
27. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Johnson SC; Yanos ME; Kayser EB; Quintana A; Sangesland M; Castanza A; Uhde L; Hui J; Wall VZ; Gagnidze A; Oh K; Wasko BM; Ramos FJ; Palmiter RD; Rabinovitch PS; Morgan PG; Sedensky MM; Kaeberlein M Science; 2013 Dec; 342(6165):1524-8. PubMed ID: 24231806 [TBL] [Abstract][Full Text] [Related]
28. Aberrant BCAA and glutamate metabolism linked to regional neurodegeneration in a mouse model of Leigh syndrome. Terburgh K; Coetzer J; Lindeque JZ; van der Westhuizen FH; Louw R Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166082. PubMed ID: 33486097 [TBL] [Abstract][Full Text] [Related]
29. Leigh syndrome: neuropathology and pathogenesis. Lake NJ; Bird MJ; Isohanni P; Paetau A J Neuropathol Exp Neurol; 2015 Jun; 74(6):482-92. PubMed ID: 25978847 [TBL] [Abstract][Full Text] [Related]
30. Targeting NAD Lee CF; Caudal A; Abell L; Nagana Gowda GA; Tian R Sci Rep; 2019 Feb; 9(1):3073. PubMed ID: 30816177 [TBL] [Abstract][Full Text] [Related]
31. Proteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) gene. Leong DW; Komen JC; Hewitt CA; Arnaud E; McKenzie M; Phipson B; Bahlo M; Laskowski A; Kinkel SA; Davey GM; Heath WR; Voss AK; Zahedi RP; Pitt JJ; Chrast R; Sickmann A; Ryan MT; Smyth GK; Thorburn DR; Scott HS J Biol Chem; 2012 Jun; 287(24):20652-63. PubMed ID: 22535952 [TBL] [Abstract][Full Text] [Related]
32. Iron status influences mitochondrial disease progression in Complex I-deficient mice. Kelly CJ; Couch RK; Ha VT; Bodart CM; Wu J; Huff S; Herrel NT; Kim HD; Zimmermann AO; Shattuck J; Pan YC; Kaeberlein M; Grillo AS Elife; 2023 Feb; 12():. PubMed ID: 36799301 [TBL] [Abstract][Full Text] [Related]
33. A constant and similar assembly defect of mitochondrial respiratory chain complex I allows rapid identification of NDUFS4 mutations in patients with Leigh syndrome. Assouline Z; Jambou M; Rio M; Bole-Feysot C; de Lonlay P; Barnerias C; Desguerre I; Bonnemains C; Guillermet C; Steffann J; Munnich A; Bonnefont JP; Rötig A; Lebre AS Biochim Biophys Acta; 2012 Jun; 1822(6):1062-9. PubMed ID: 22326555 [TBL] [Abstract][Full Text] [Related]
34. Leigh Syndrome Due to Borna NN; Kishita Y; Sakai N; Hamada Y; Kamagata K; Kohda M; Ohtake A; Murayama K; Okazaki Y Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33182419 [TBL] [Abstract][Full Text] [Related]
35. Impaired hypoxic pulmonary vasoconstriction in a mouse model of Leigh syndrome. Schleifer G; Marutani E; Ferrari M; Sharma R; Skinner O; Goldberger O; Grange RMH; Peneyra K; Malhotra R; Wepler M; Ichinose F; Bloch DB; Mootha VK; Zapol WM Am J Physiol Lung Cell Mol Physiol; 2019 Feb; 316(2):L391-L399. PubMed ID: 30520688 [TBL] [Abstract][Full Text] [Related]
36. The NDUFS4 Knockout Mouse: A Dual Threat Model of Childhood Mitochondrial Disease and Normative Aging. Grillo AS; Bitto A; Kaeberlein M Methods Mol Biol; 2021; 2277():143-155. PubMed ID: 34080150 [TBL] [Abstract][Full Text] [Related]
37. Gait analysis in a mouse model resembling Leigh disease. de Haas R; Russel FG; Smeitink JA Behav Brain Res; 2016 Jan; 296():191-198. PubMed ID: 26363424 [TBL] [Abstract][Full Text] [Related]
38. Biallelic variants in two complex I genes cause abnormal splicing defects in probands with mild Leigh syndrome. Johnstone T; Wang J; Ross D; Balanda N; Huang Y; Godfrey R; Groden C; Barton BR; Gahl W; Toro C; Malicdan MCV Mol Genet Metab; 2020; 131(1-2):98-106. PubMed ID: 33097395 [TBL] [Abstract][Full Text] [Related]